Kevin
Mack‡
abc,
Moritz
Doeker‡
cd,
Laura
Grabowski
abc,
Andreas
Jupke
cd and
Dörte
Rother
*abc
aForschungszentrum Jülich GmbH IBG-1, Wilhelm-Johnen-Straße, 52425 Jülich, Germany. E-mail: do.rother@fz-juelich.de; Fax: +49 2461 61-3870; Tel: +49 2461 61-6772
bRWTH Aachen University ABBt, Worringer Weg 1, 52056 Aachen, Germany
cBioeconomy Science Center (BioSC), Forschungszentrum Jülich, Jülich, Germany
dRWTH Aachen University AVT, Forckenbeckstraße 51, 52056 Aachen, Germany
First published on 7th June 2021
Vicinal amino alcohols such as metaraminol find direct application in pharmaceuticals and serve as building blocks for fine chemicals. The amine transaminase enzyme can facilitate the stereoselective production of such amino alcohols, which have two chiral centers, e.g. by transamination from 2-hydroxy ketones in the presence of an amine donor. The feasibility of enzymatic metaraminol production has already been demonstrated with the amine donor isopropylamine. This amine donor has the drawback of an unfavorable reaction equilibrium for the target reaction and being crude oil-based. Therefore, we substituted isopropylamine with the bio-based amine donor L-alanine. As the transamination reaction is also thermodynamically limited when utilizing L-alanine, in situ liquid–liquid extraction of metaraminol can solve this drawback and was implemented to increase the conversions and initiate downstream processing steps. We investigated a suitable solvent–enzyme combination and determined a distinct operational window in terms of reaction conditions for combining the enzymatic metaraminol production with product extraction in a smart process concept. This study thus presents a powerful example for the use of the bio-based amine donor L-alanine in combination with efficient process intensification of biocatalytic drug synthesis by means of in situ product removal.
Recently, efforts to integrate precursors from renewable feedstock into (chemo-) enzymatic cascades have been made to establish fully bio-based conversion routes to high value chemicals and pharmaceuticals.5 Fortunately, the large substrate spectrum of transaminases, partly exploited by extensive protein engineering advances, supports the use of sustainable catalysts for these applications and enlarges the possible product spectrum.6,7 Nonetheless, enzyme-catalyzed transamination often exhibits an unfavorable reaction equilibrium resulting in low product titers.8,9 To overcome these limitations, intensive prediction studies have taken place and showed a mild shift of the equilibrium while adjusting the pH and temperature of the reaction.10 Many other transaminase reactions make use of large amounts of the cheap, oil-based amine donor isopropylamine (IPA), producing acetone as the side product. Acetone can be removed via evaporation during the reaction, thus realizing an equilibrium shift to higher product titers,11 while ultimately reducing the overall atom efficiency of the process and leading to excess organic solvent waste. A combination of shifting the equilibrium while simultaneously removing the desired amine product from the reaction phase would be desired. In fact, several drawbacks are evident while using IPA as an amine donor: while there can be little to no activity of wild type amine transaminases towards IPA,12,13 also undesired side reactions can arise from the basicity of the amine donor.14 Furthermore, IPA is highly toxic, derived from fossil resources and complicates the downstream processing, which stands in the way of a sustainable production process with little residual, polluting waste streams. Another amine donor can be α-methylbenzylamine, which has the drawback of being a chiral compound and therefore entails higher costs, sharing the problem of atom efficiency as well.15 Alternative amine donors are the natural products of transaminases. These can be amino acids such as L-alanine, which is non-toxic and was shown to be a favorable co-substrate for the transaminase catalyzed transamination of pro-chiral precursors.16 In addition, L-alanine can be produced in microbial transformations from bio-based sugars. However, the major challenge of utilizing L-alanine for transamination reactions remain very low conversions due to a thermodynamic limitation when stoichiometric amounts are applied. To overcome this limitation, measures to shift the reaction equilibrium, predominantly by in situ product removal (ISPR), are a possible solution.
Established ISPR strategies are in situ product crystallization17 or supported liquid membrane product extraction,18 which were both shown with IPA as an amine donor. Common challenges of in situ product crystallization are (i) the choice of a suitable precipitation agent and (ii) the subsequent product recovery from the precipitate. Supported liquid membranes on the other hand suffer from membrane fouling when the crude cell extract is applied. Further strategies to shift the reaction equilibria involve the enzymatic depletion of the co-product using an additional enzymatic reaction, as shown for the in situ product removal of pyruvate.19,20 However, co-product removal also lowers the atom efficiency of the process and the required auxiliary enzymes heavily increase the overall operating costs and system complexity. Moreover, such strategies do not serve product purification purposes or alleviate possible product inhibition effects. In addition, none of the mentioned ISPR strategies have been applied to enzymatic cascades targeting metaraminol. Hence, alternative methods for a robust, efficient, and scalable product recovery are sought. One such alternative method is liquid–liquid extraction (LLE), which was already shown to be applicable to some enzymatic systems.21 In this contribution, we show that the integration of in situ LLE in the biocatalytic production of metaraminol allows for enhanced process productivity when an amine donor from renewable resources is applied.
For the long-term initial activity assays (section 3.2), purified and lyophilized Cv2025 was incubated in 50 mM HEPES buffer pH 7.5, which was pre-saturated with the respective organic solvents. Pre-saturation was accomplished by mixing the respective solvent with the buffer and incubating this mixture for 24 h. After that, the organic solvent was discarded and only a monophasic buffer, with trace amounts of soluble organic solvent, remained and was applied subsequently. The enzyme concentration was determined via the Bradford assay. After distinct incubation times, the enzyme initial activity was measured in a quartz glass cuvette (d = 1 cm) at 25 °C by acetophenone production at 300 nm using a UV-Vis spectrophotometer (final concentrations in the assay: 50 mM HEPES buffer pH 7.5, 0.1 mM PLP, 2.5 mM α-methylbenzylamine, 5 mM pyruvate, 0.1 mg mL−1 enzyme). Under the stated conditions, one Unit (U) is defined as the amount of catalyst producing one μmol acetophenone per minute. This standard assay for transaminases was first published elsewhere.24
![]() | (1) |
For repeated batch mode experiments, the organic phase was back extracted after 4, 6 and 24 h and the samples were taken from the aqueous phases as described before. Larger reactions (40 mL) were performed in a 100 mL stirred-tank reactor (EasyMax 402, Mettler Toledo; Columbus, US) at 30 °C and with the addition of pH control by automatic titration of 1 M NaOH. For product recovery, the organic extraction phase was transferred to an acidic aqueous phase (50 mM tartaric acid, 25 °C, stirred at 600 rpm for 1 h). To aid in phase separation, biphasic systems were transferred to Falcon reaction tubes (50 mL) and centrifuged (4000 rpm, 10 °C, 10 min). Afterwards, the samples were taken from the aqueous reaction and back extraction phases and analyzed separately via HPLC analysis. Reference reactions without organic overlay were performed under identical process conditions at pH 7.0 (40 mL reaction phase, 40 mM (R)-3-OH-PAC, 250 mM L-alanine, 1 mM PLP, 100 mM HEPES, 10 mg mL−1 lyophilized, whole cells Cv2025).
![]() | (2) |
The metaraminol yield was defined as the total amount of produced metaraminol from the supplied amount of substrate (R)-3-OH-PAC as shown in the following equation:
![]() | (3) |
The selectivity (eqn (5)) of the reaction step was used to assess the amount of unwanted (chemical) side reactions as follows:
![]() | (4) |
![]() | (5) |
For the efficient conversion of (R)-3-OH-PAC to metaraminol, Cv2025 transaminase must further exhibit high tolerance to organic solvents to enable in situ extraction within the enzymatic reaction system. The use of solvents within an enzymatic reaction can influence the activity, the stability or even the (stereo)selectivity of the enzyme.25 To validate this organic solvent tolerance, we determined the activity of Cv2025 transaminase for different organic solvents (Fig. 2). For this purpose, the reaction towards metaraminol was investigated using IPA as an amine donor. The use of IPA in excess allowed the exclusion of the limiting reaction equilibrium for transamination with L-alanine.
To obtain an economically efficient extraction process, organic solvent losses must be minimized. One main reason for the loss of organic solvents is the cross solubility in the aqueous phase, as the recovery of the dissolved solvent is rarely possible. Therefore, extraction systems with low water solubility are required. The degree of cross solubility of different solvents may be compared via the logP value, which describes the logarithmic distribution coefficient of a compound in a biphasic system of 1-octanol and water (log
c1-octanol/cwater). In the initial solvent screening, high cross solubility was observed for 2-propanol, ethyl acetate, 1-propanol, tert-butanol and 1-butanol, which are not suitable for the extraction. Furthermore, these 5 solvents and 1-hexanol lead to inactivation of the catalyst. The remaining 6 solvents showed similar or better conversion of (R)-3-OH-PAC to metaraminol when compared to the reference without solvent addition. From the best performing solvents with respect to conversion in the screening, 1-decanol and 1-octanol exhibit a low distribution towards water.26 As both solvents also showed the highest conversions in the enzymatic system, without observable interface inactivation, both were chosen for further experiments.
The dissociation behavior and respective pKa values were analyzed by titration experiments with commercial metaraminol bitartrate. The pKa values of tartaric acid were found to be 3.3 and 4.4, whereas the pKa values of metaraminol were approximated to 8.9 and 10.2 (Fig. 4) and confirmed in three separate experiments. The results for metaraminol are within the expected pKa range for the amino and phenolic groups, which varies slightly from a previously published pKa value of 8.6.27 Unfortunately, the publication does not clarify the method for pKa determination, which could explain the deviation from our findings.
![]() | ||
Fig. 4 Titration of metaraminol bitartrate with NaOH. The pKa values for the tartaric acid (yellow, pKa1 = 3.3, pKa2 = 4.4) and metaraminol (blue, pKa1 = 8.9, pKa2 = 10.2) are highlighted. |
The assignment of the determined pKa values to the functional groups can be difficult. Nevertheless, a comparison with well-characterized compounds such as norephedrine, having only the amino group and therewith one pKa value, allows the matching of the ascertained pKa1 value of 8.9 to the amino group and conclusively the pKa2 = 10.2 to the hydroxyl group. The isoelectric point (IEP) of metaraminol was determined to be pH 9.55. Thus, three different dissociation states of metaraminol can be defined. At low pH values, metaraminol is mostly present in its cationic form, between both pKa values it is mostly net neutral and above the upper pKa metaraminol is present in its anionic form. These results are in line with the experimental data available for similar amino alcohols.28 The titration of the substrate (R)-3-OH-PAC resulted in a pKa value of 9.6, corresponding to the dissociation of the hydroxyl group at the aromatic ring (Fig. 5).
![]() | ||
Fig. 5 Titration of (R)-3-OH-PAC with NaOH. The pKa value for the hydroxy group can be estimated at pH 9.6. |
As a consequence, the protonation states of metaraminol and (R)-3-OH-PAC should be reflected by pH-dependent phase distributions in physical extraction experiments, which were investigated and verified in the following pH dependent liquid–liquid extraction studies.
![]() | ||
Fig. 6 Extraction yield of metaraminol at different pH values using 1-decanol as the extraction solvent. Error bars show the range of two technical replicates. |
![]() | ||
Fig. 7 Extraction yield of (R)-3-OH-PAC from aqueous solutions at different pH values using 1-decanol as the extraction solvent. Error bars indicate the range of two independent measurements. |
The pH dependent extraction behavior of metaraminol is shown in Fig. 6. At pH levels below 7.75 negligible distribution to the organic phase was observed. Here, metaraminol is mostly present in its cationic form, which shows very low affinity for an aliphatic organic phase and thus low concentration in the organic phase was expected. Above pH 7.9, an increase of the distribution of metaraminol towards the organic phase can be observed until the maximal extraction yield was reached at pH 9.6. This increase in the extraction yield in the organic phase is due to the shift of the metaraminol species towards the neutral state, which has zero net charge and can thus be physically extracted. The experimentally verified results thus coincide with the estimated isoelectric point of metaraminol. Here, the highest measured extraction yield for metaraminol was 18%. A further increase of pH leads to a decrease of the neutral metaraminol species in favor of the anionic metaraminol species. This anionic species shows again lower affinity for the organic phase. Therefore, physical extraction of metaraminol is only possible around the isoelectric point and thus limits the operating pH range of the enzymatic reaction. Recovery of metaraminol from the organic phase can be realized by contacting the loaded organic phase with an acidic aqueous phase. The low pH of the back extraction phase causes protonation of metaraminol to its cationic form, while being transferred to the acidic aqueous phase. In all experiments, the determined recovery rate of metaraminol by back extraction was between 80% and 95%. Any discrepancies to complete full back extraction are due to metaraminol losses during handling of the samples and HPLC detection accuracy limits.
Similar to the results for the extraction behavior of metaraminol, dissociation states of (R)-3-OH-PAC influence the distribution between the organic and aqueous phases. The liquid–liquid extraction results for (R)-3-OH-PAC in the pH range of 7.0–10.5 are shown in Fig. 7. A maximal extraction yield of 60% was observed at pH 7.0, which decreased with higher pH values. Thus, significant amounts of (R)-3-OH-PAC will be present in the organic phase during the enzymatic reaction. This allows the organic phase to function as a reservoir for (R)-3-OH-PAC with a constant refeed, when (R)-3-OH-PAC is consumed in the aqueous reaction phase, while simultaneously trapping metaraminol. During back extraction, the remaining (R)-3-OH-PAC will also distribute into the acidic aqueous phase. This may be countered by a continuous operation mode where the equilibrium shift of the reaction towards metaraminol will constantly lower (R)-3-OH-PAC concentrations in the organic phase and thus also lower concentrations present in the acidic aqueous phase. We concluded that a pH of around 9.6 and back extraction in an acidic phase would be the optimal setup for the physical extraction of metaraminol. A schematic view of the setup with the in situ extraction including the distribution of (R)-3-OH-PAC and metaraminol is shown in Fig. 8.
Here, borate and phosphate buffers were used to ensure the buffer capacity in the alkaline pH range, which is known to be suitable for transaminase reaction systems.18 Since pH values ≥ pH 9.0 showed lower activity of Cv2025 (refer to Fig. S1.1 and S1.2 in the ESI†), pH 8.5–9.0 was considered a suitable compromise for metaraminol production and extraction. Specifically with regard to an industrial scope, whole cell biocatalysts are favored over purified enzymes because of easier handling and substantial cost savings.30
The batch ISPR experiments were scaled up to biphasic systems (60 mL total volume) and performed in a stirred reactor, as this facilitated pH control and high mixing to ensure optimal mass transfer between the organic extraction phase and the aqueous reaction phase. Higher organic phase ratios were used when compared to the long-term initial enzyme activity experiments. These higher organic phase ratios were required for efficient extraction of metaraminol and have no influence on the stability of the enzymatic catalyst, as in both cases the maximal cross solubility of the organic solvent in the aqueous phase was reached and sufficient organic phase remained to ensure the formation of a two-phasic liquid system.31
For comparison, two control experiments at pH 7.0 and 9.0 without ISPR were performed prior to the ISPR assays. Then the ISPR setup at pH 9.0 with a single extraction step was tested as well as the ISPR setup at pH 8.5 with repeated batches. The results of the investigation are shown in Fig. 9.
The reaction setup at pH 7.0 without ISPR showed a low product yield of 14%, which was to be expected since the reaction equilibrium with L-alanine is largely on the substrate side. Furthermore, a good selectivity of above 85% was observed. An increase of pH to 9.0 without integration of the ISPR resulted in the same yield as that measured at pH 7.0 while the selectivity dropped to 25%. One explanation for this sharp drop in selectivity may be the formation of imines (see the ESI, Fig. S5.7†), as these side products can form when a constant alkaline pH is applied.32 By integrating ISPR with the enzymatic synthesis at pH 9.0, an increase of the metaraminol yield from 14 to 24% was achieved. This increase is due to the extraction of the metaraminol to the organic phase and the accompanying shift of the reaction equilibrium via ISPR. In addition, an increase of selectivity from 25% to over 40% compared to the enzymatic experiment at pH 9.0 without ISPR was observed. This indicates that both selectivity and yield can be improved by the presented ISPR technique. Nevertheless, the yield and selectivity observed at pH 9.0, with one stage batch extraction, are not sufficient for efficient production of metaraminol.
To further increase the yield and selectivity, we chose to slightly adapt the operating pH to 8.5. This reduction of the operating pH leads to an increase in selectivity at the cost of a lower single stage extraction yield. To cope with the reduction of the single stage extraction yield and to increase the overall achievable yield, three repeated batch extractions were performed after 4, 6 and 24 hours of the experiments. As can be seen in Fig. 9, the operation in the repeated batch mode allowed even higher yields of up to 29%, which is double the equilibrium yield without ISPR. Furthermore, the repeated batch operation at pH 8.5 allowed for a significant increase in the selectivity of the reaction to up to 68%, which is already close to the 85% selectivity achieved at pH 7.0. During all experiments, the reaction mixtures were carefully monitored for precipitation in the aqueous and organic phases, and we could not observe any precipitation in the reaction mixtures. Concluding this investigation, these results suggest that a continuous extraction and back extraction process within metaraminol production should be established to further increase the yield and selectivity. In this regard, Matassa et al. have demonstrated the successful application of membrane modules to increase the extraction yield and retaining of the biocatalyst.33 Furthermore, the accumulation of pyruvate in the reaction medium, which did not significantly influence the activity and stability of the enzymatic catalyst, can be recycled. Another advantage of a continuous process is the possibility of a substrate feeding strategy to further increase the overall productivity.
Aside from the clear optimization potential, the integration of extraction-based ISPR served three main purposes in the presented application. Firstly, the reaction equilibrium was shifted towards the product side and the biocatalyst yield was increased. Secondly, product isolation and recovery were implemented, either initiating complete downstream processing of the product or providing metaraminol in an acidic aqueous phase for subsequent chemoenzymatic modifications. Finally, applying a biphasic reaction system enabled in situ substrate supply via the organic phase, which can be especially beneficial for substrates with low solubility in aqueous reaction phases.34,35 The presented concept is expected to be transferable to the biocatalytic synthesis of a range of amino alcohols and chiral amines, although the operational conditions such as the applicable pH range and the optimal solvent must be determined for each biocatalyst and substrate system individually. Following the results of this investigation, a more detailed solvent screening, based on thermodynamic modelling, would be an interesting target, as this would further clarify the influence of different solvents and provide additional solvent candidates. For this, approaches based on COSMO-RS or PC-SAFT could be used.36,37 Furthermore, as this publication focuses on standard organic solvents, alternative solvents such as deep eutectic solvents can be the target of further investigations. These alternative solvents are known to influence the enzyme performance and might be useful to further optimize the enzymatic reaction system.38
By integrating the ISPR concept with the enzymatic reaction, the utilization of L-alanine as a bio-based amine donor was enabled by circumventing the unfavorable reaction equilibrium, accomplishing increased conversions and efficient product recovery by back extraction. As extraction efficiencies remained limited in the batch mode, a repeated batch mode was investigated, achieving a maximum metaraminol yield of 29% compared to 14% conversion without ISPR. It is expected that a continuous setup might be a good strategy to further enhance the overall process performance. Additionally, thermodynamic modelling, such as that conducted by Voges et al. in 2017 for another transaminase reaction, could further improve the shown concept.10 Conclusively, an operational window for simultaneous transamination and product extraction was defined within an economically and ecologically feasible framework.
The use of biocatalysts combined with the defined ISPR concept facilitates the use of highly stereoselective conversion routes under mild reaction conditions and is independent of harmful auxiliaries, thus avoiding toxic and polluting waste products and simultaneously facilitating a first purification step of metaraminol. Also the recycling of reaction components such as organic solvents further increases the greenness of the overall reaction. The utilized co-substrate L-alanine can be derived from renewable feedstock and is deaminated in the enzymatic reaction to the co-product pyruvate. In a preceding reaction step within the enzymatic cascade to metaraminol, pyruvate can be carboligated with 3-OH-benzaldehyde to yield (R)-3-OH-PAC as was shown for a similar reaction for the synthesis of nor(pseudo)ephedrines.31 By recycling pyruvate from the ISPR concept, the two-step enzyme cascade to metaraminol can accomplish a high atom economy. This concept is not only limited to the presented reaction but can also be applied within similar transaminase reactions contributing to an overall sustainable value chain to chiral amines. Simultaneously, we wanted to create awareness that the reaction setup and downstream processing go hand in hand and should be set up in conjunction to avoid unfavorable component choices and reaction conditions. In this way, the presented concept complies with the major key principles of green chemistry, highlighting the unique capability of integrated bioprocessing towards greener pharmaceutical and fine chemical manufacturing.
Footnotes |
† Electronic supplementary information (ESI) available. See DOI: 10.1039/D1GC00852H |
‡ These authors contributed equally to this work. |
This journal is © The Royal Society of Chemistry 2021 |